{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T18:52:46Z","timestamp":1781722366236,"version":"3.54.5"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T00:00:00Z","timestamp":1736121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T00:00:00Z","timestamp":1736121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Ministry of Education, Culture, Sports, Science and Technology of the Japanese government"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-85528-8","type":"journal-article","created":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T06:00:45Z","timestamp":1736143245000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Regulation of innate immune response by miRNAs up-regulated in Stevens-Johnson syndrome with severe ocular complications"],"prefix":"10.1038","volume":"15","author":[{"given":"Mayumi","family":"Ueta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromi","family":"Nishigaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hokoru","family":"Yoshioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chie","family":"Sotozono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,6]]},"reference":[{"issue":"2","key":"85528_CR1","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ajo.2015.05.002","volume":"160","author":"C Sotozono","year":"2015","unstructured":"Sotozono, C. et al. Predictive factors associated with acute ocular involvement in Stevens-Johnson syndrome and toxic epidermal necrolysis. Am. J. Ophthalmol. 160 (2), 228\u2013237 (2015). e222.","journal-title":"Am. J. Ophthalmol."},{"issue":"3","key":"85528_CR2","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1080\/1744666X.2020.1729128","volume":"16","author":"M Ueta","year":"2020","unstructured":"Ueta, M. Stevens-Johnson syndrome\/toxic epidermal necrolysis with severe ocular complications. Expert Rev. Clin. Immunol. 16 (3), 285\u2013291 (2020).","journal-title":"Expert Rev. Clin. Immunol."},{"key":"85528_CR3","doi-asserted-by":"publisher","first-page":"651247","DOI":"10.3389\/fmed.2021.651247","volume":"8","author":"M Ueta","year":"2021","unstructured":"Ueta, M. Pathogenesis of Stevens-Johnson Syndrome\/Toxic epidermal necrolysis with severe ocular complications. Front. Med. (Lausanne). 8, 651247 (2021).","journal-title":"Front. Med. (Lausanne)"},{"key":"85528_CR4","doi-asserted-by":"publisher","first-page":"1189140","DOI":"10.3389\/fmed.2023.1189140","volume":"10","author":"M Ueta","year":"2023","unstructured":"Ueta, M. et al. Severe ocular complications of SJS\/TEN and associations among pre-onset, acute, and chronic factors: a report from the international ophthalmology collaborative group. Front. Med. (Lausanne). 10, 1189140 (2023).","journal-title":"Front. Med. (Lausanne)"},{"key":"85528_CR5","doi-asserted-by":"publisher","first-page":"4862","DOI":"10.1038\/srep04862","volume":"4","author":"M Ueta","year":"2014","unstructured":"Ueta, M. et al. Independent strong association of HLA-A*02:06 and HLA-B*44:03 with cold medicine-related Stevens-Johnson syndrome with severe mucosal involvement. Sci. Rep. 4, 4862 (2014).","journal-title":"Sci. Rep."},{"key":"85528_CR6","doi-asserted-by":"publisher","first-page":"5981","DOI":"10.1038\/srep05981","volume":"4","author":"M Ueta","year":"2014","unstructured":"Ueta, M. et al. Trans-ethnic study confirmed independent associations of HLA-A*02:06 and HLA-B*44:03 with cold medicine-related Stevens-Johnson syndrome with severe ocular surface complications. Sci. Rep. 4, 5981 (2014).","journal-title":"Sci. Rep."},{"issue":"6","key":"85528_CR7","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.preteyeres.2012.05.003","volume":"31","author":"M Ueta","year":"2012","unstructured":"Ueta, M. & Kinoshita, S. Ocular surface inflammation is regulated by innate immunity. Prog Retin Eye Res. 31 (6), 551\u2013575 (2012).","journal-title":"Prog Retin Eye Res."},{"issue":"7","key":"85528_CR8","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1136\/bjo.2006.113449","volume":"91","author":"M Ueta","year":"2007","unstructured":"Ueta, M. et al. Toll-like receptor 3 gene polymorphisms in Japanese patients with Stevens-Johnson syndrome. Br. J. Ophthalmol. 91 (7), 962\u2013965 (2007).","journal-title":"Br. J. Ophthalmol."},{"issue":"5","key":"85528_CR9","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1016\/j.jaci.2012.01.069","volume":"129","author":"M Ueta","year":"2012","unstructured":"Ueta, M. et al. Epistatic interaction between toll-like receptor 3 (TLR3) and prostaglandin E receptor 3 (PTGER3) genes. J. Allergy Clin. Immunol. 129 (5), 1413\u20131416e1411 (2012).","journal-title":"J. Allergy Clin. Immunol."},{"issue":"8","key":"85528_CR10","doi-asserted-by":"publisher","first-page":"e43650","DOI":"10.1371\/journal.pone.0043650","volume":"7","author":"M Ueta","year":"2012","unstructured":"Ueta, M. et al. HLA-A*0206 with TLR3 polymorphisms exerts more than additive effects in Stevens-Johnson syndrome with severe ocular surface complications. PLoS One. 7 (8), e43650 (2012).","journal-title":"PLoS One"},{"issue":"6","key":"85528_CR11","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1016\/j.jaci.2010.08.007","volume":"126","author":"M Ueta","year":"2010","unstructured":"Ueta, M. et al. Association between prostaglandin E receptor 3 polymorphisms and Stevens-Johnson syndrome identified by means of a genome-wide association study. J. Allergy Clin. Immunol. 126 (6), 1218\u20131225e1210 (2010).","journal-title":"J. Allergy Clin. Immunol."},{"key":"85528_CR12","doi-asserted-by":"publisher","first-page":"15023","DOI":"10.1038\/hgv.2015.23","volume":"2","author":"M Ueta","year":"2015","unstructured":"Ueta, M. et al. HLA-A*02:06 and PTGER3 polymorphism exert additive effects in cold medicine-related Stevens-Johnson syndrome with severe ocular complications. Hum. Genome Var. 2, 15023 (2015).","journal-title":"Hum. Genome Var."},{"key":"85528_CR13","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13601-019-0300-9","volume":"9","author":"P Chantaren","year":"2019","unstructured":"Chantaren, P. et al. Association of IKZF1 SNPs in cold medicine-related Stevens-Johnson syndrome in Thailand. Clin. Transl. Allergy. 9, 61 (2019).","journal-title":"Clin. Transl. Allergy"},{"issue":"6","key":"85528_CR14","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1016\/j.jaci.2014.12.1916","volume":"135","author":"M Ueta","year":"2015","unstructured":"Ueta, M. et al. IKZF1, a new susceptibility gene for cold medicine-related Stevens-Johnson syndrome\/toxic epidermal necrolysis with severe mucosal involvement. J. Allergy Clin. Immunol. 135 (6), 1538\u20131545e1517 (2015).","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"85528_CR15","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/jid.2014.402","volume":"135","author":"N Nakamura","year":"2015","unstructured":"Nakamura, N., Tamagawa-Mineoka, R., Ueta, M., Kinoshita, S. & Katoh, N. Toll-like receptor 3 increases allergic and irritant contact dermatitis. J. Invest. Dermatol. 135 (2), 411\u2013417 (2015).","journal-title":"J. Invest. Dermatol."},{"issue":"5","key":"85528_CR16","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.jaci.2009.03.008","volume":"123","author":"M Ueta","year":"2009","unstructured":"Ueta, M., Uematsu, S., Akira, S. & Kinoshita, S. Toll-like receptor 3 enhances late-phase reaction of experimental allergic conjunctivitis. J. Allergy Clin. Immunol. 123 (5), 1187\u20131189 (2009).","journal-title":"J. Allergy Clin. Immunol."},{"issue":"4","key":"85528_CR17","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.jaci.2009.04.029","volume":"124","author":"T Honda","year":"2009","unstructured":"Honda, T. et al. Prostaglandin E(2)-EP(3) signaling suppresses skin inflammation in murine contact hypersensitivity. J. Allergy Clin. Immunol. 124 (4), 809\u2013818e802 (2009).","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"85528_CR18","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.jaci.2008.09.044","volume":"123","author":"M Ueta","year":"2009","unstructured":"Ueta, M., Matsuoka, T., Narumiya, S. & Kinoshita, S. Prostaglandin E receptor subtype EP3 in conjunctival epithelium regulates late-phase reaction of experimental allergic conjunctivitis. J. Allergy Clin. Immunol. 123 (2), 466\u2013471 (2009).","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"85528_CR19","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/all.13308","volume":"73","author":"M Ueta","year":"2018","unstructured":"Ueta, M. et al. Mucocutaneous inflammation in the Ikaros Family Zinc Finger 1-keratin 5-specific transgenic mice. Allergy 73 (2), 395\u2013404 (2018).","journal-title":"Allergy"},{"issue":"2\u20133","key":"85528_CR20","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.brainresbull.2009.10.001","volume":"81","author":"M Ueta","year":"2010","unstructured":"Ueta, M. & Kinoshita, S. Innate immunity of the ocular surface. Brain Res. Bull. 81 (2\u20133), 219\u2013228 (2010).","journal-title":"Brain Res. Bull."},{"key":"85528_CR21","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.jtos.2021.05.008","volume":"21","author":"M Ueta","year":"2021","unstructured":"Ueta, M. et al. Regulation of innate immune response by mir-628-3p upregulated in the plasma of Stevens-Johnson syndrome patients. Ocul Surf. 21, 174\u2013177 (2021).","journal-title":"Ocul Surf."},{"key":"85528_CR22","doi-asserted-by":"publisher","first-page":"1025539","DOI":"10.3389\/fgene.2022.1025539","volume":"13","author":"M Ueta","year":"2022","unstructured":"Ueta, M. et al. Positive regulation of innate immune response by miRNA-let-7a-5p. Front. Genet. 13, 1025539 (2022).","journal-title":"Front. Genet."},{"issue":"4","key":"85528_CR23","first-page":"161","volume":"2","author":"AM Ardekani","year":"2010","unstructured":"Ardekani, A. M. & Naeini, M. M. The role of MicroRNAs in human diseases. Avicenna J. Med. Biotechnol. 2 (4), 161\u2013179 (2010).","journal-title":"Avicenna J. Med. Biotechnol."},{"issue":"1","key":"85528_CR24","doi-asserted-by":"publisher","first-page":"17239","DOI":"10.1038\/s41598-020-74211-9","volume":"10","author":"M Ueta","year":"2020","unstructured":"Ueta, M. et al. Regulation of gene expression by miRNA-455-3p, upregulated in the conjunctival epithelium of patients with Stevens-Johnson syndrome in the chronic stage. Sci. Rep. 10 (1), 17239 (2020).","journal-title":"Sci. Rep."},{"issue":"11","key":"85528_CR25","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1080\/14728222.2018.1535594","volume":"22","author":"ME Gilles","year":"2018","unstructured":"Gilles, M. E. & Slack, F. J. Let-7 microRNA as a potential therapeutic target with implications for immunotherapy. Expert Opin. Ther. Targets. 22 (11), 929\u2013939 (2018).","journal-title":"Expert Opin. Ther. Targets"},{"issue":"3","key":"85528_CR26","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1182\/blood.2019002045","volume":"135","author":"YL Su","year":"2020","unstructured":"Su, Y. L. et al. Myeloid cell-targeted miR-146a mimic inhibits NF-kappaB-driven inflammation and leukemia progression in vivo. Blood 135 (3), 167\u2013180 (2020).","journal-title":"Blood"},{"issue":"1","key":"85528_CR27","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13287-020-02068-w","volume":"12","author":"J Sun","year":"2021","unstructured":"Sun, J. et al. microRNA-27b shuttled by mesenchymal stem cell-derived exosomes prevents sepsis by targeting JMJD3 and downregulating NF-kappaB signaling pathway. Stem Cell. Res. Ther. 12 (1), 14 (2021).","journal-title":"Stem Cell. Res. Ther."},{"key":"85528_CR28","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.biocel.2016.02.021","volume":"74","author":"H Zheng","year":"2016","unstructured":"Zheng, H. et al. Regulation and mechanism of mouse miR-130a\/b in metabolism-related inflammation. Int. J. Biochem. Cell. Biol. 74, 72\u201383 (2016).","journal-title":"Int. J. Biochem. Cell. Biol."},{"key":"85528_CR29","doi-asserted-by":"crossref","unstructured":"Chen, L. et al. IFITM2 presents antiviral response through enhancing type I IFN signaling pathway. Viruses 15 (4) (2023).","DOI":"10.3390\/v15040866"},{"key":"85528_CR30","doi-asserted-by":"crossref","unstructured":"DeDiego, M. L., Martinez-Sobrido, L. & Topham, D. J. Novel functions of IFI44L as a feedback regulator of host antiviral responses. J. Virol. 93 (21) (2019).","DOI":"10.1128\/JVI.01159-19"},{"issue":"9","key":"85528_CR31","doi-asserted-by":"publisher","first-page":"7257","DOI":"10.1074\/jbc.M110.207068","volume":"286","author":"M Stawowczyk","year":"2011","unstructured":"Stawowczyk, M., Van Scoy, S., Kumar, K. P. & Reich, N. C. The interferon stimulated gene 54 promotes apoptosis. J. Biol. Chem. 286 (9), 7257\u20137266 (2011).","journal-title":"J. Biol. Chem."},{"issue":"2","key":"85528_CR32","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1128\/JVI.78.2.585-594.2004","volume":"78","author":"MJ Trifilo","year":"2004","unstructured":"Trifilo, M. J. et al. CXC chemokine ligand 10 controls viral infection in the central nervous system: evidence for a role in innate immune response through recruitment and activation of natural killer cells. J. Virol. 78 (2), 585\u2013594 (2004).","journal-title":"J. Virol."},{"issue":"2\u20133","key":"85528_CR33","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s12026-011-8228-8","volume":"50","author":"NL Vujanovic","year":"2011","unstructured":"Vujanovic, N. L. Role of TNF superfamily ligands in innate immunity. Immunol. Res. 50 (2\u20133), 159\u2013174 (2011).","journal-title":"Immunol. Res."},{"issue":"2","key":"85528_CR34","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/eji.201545839","volume":"46","author":"SM Man","year":"2016","unstructured":"Man, S. M., Karki, R. & Kanneganti, T. D. AIM2 inflammasome in infection, cancer, and autoimmunity: role in DNA sensing, inflammation, and innate immunity. Eur. J. Immunol. 46 (2), 269\u2013280 (2016).","journal-title":"Eur. J. Immunol."},{"issue":"8","key":"85528_CR35","doi-asserted-by":"publisher","first-page":"4523","DOI":"10.1128\/JVI.02548-12","volume":"87","author":"A Di Pietro","year":"2013","unstructured":"Di Pietro, A. et al. TRIM22 inhibits influenza a virus infection by targeting the viral nucleoprotein for degradation. J. Virol. 87 (8), 4523\u20134533 (2013).","journal-title":"J. Virol."},{"key":"85528_CR36","doi-asserted-by":"publisher","first-page":"1176177","DOI":"10.3389\/fmicb.2023.1176177","volume":"14","author":"L Villamayor","year":"2023","unstructured":"Villamayor, L. et al. The IFN-stimulated gene IFI27 counteracts innate immune responses after viral infections by interfering with RIG-I signaling. Front. Microbiol. 14, 1176177 (2023).","journal-title":"Front. Microbiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-85528-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-85528-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-85528-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T06:02:48Z","timestamp":1736143368000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-85528-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,6]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["85528"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-85528-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,6]]},"assertion":[{"value":"25 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"893"}}